Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. - Wikidata - awgldk - TriplyDB

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

http://www.wikidata.org/entity/Q36838201

about

Lorcaserin for overweight or obese adults Lorcaserin for overweight or obese adults Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesity Neuroinflammatory basis of metabolic syndrome Phospholipase C-related catalytically inactive protein can regulate obesity, a state of peripheral inflammation.Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver.Effects of infant weight gain on subsequent allergic outcomes in the first 3 years of life.Obesity and microbiota: an example of an intricate relationship.Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study.Gastrointestinal morbidity in obesity.DNA methylation modifications associated with chronic fatigue syndrome.Low-grade dietary-related inflammation and survival after colorectal cancer surgery.Unraveling the complex relationship triad between lipids, obesity, and inflammation Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice.Antioxidant and associated capacities of Camu camu (Myrciaria dubia): a systematic review.Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.Application of multiplex arrays for cytokine and chemokine profiling of bile Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort Non-alcoholic fatty liver disease, diet and gut microbiota.Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population.Red cell distribution width in type 2 diabetic patients High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.Clinical Relevance of Transforming Growth Factor-β1, Interleukin-6 and Haptoglobin for Prediction of Obesity Complications in Prepubertal Egyptian Children Effect of Acupuncture on Body Weight Reduction and Inflammatory Mediators in Egyptian Obese Patients Dynamics of biomarkers in relation to aging and mortality.Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines.Immunometabolism in obese asthmatics: are we there yet?Vitamin D status and circulating biomarkers of endothelial dysfunction and inflammation in non-diabetic obese individuals: a pilot study.Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study.Obesity and cytokines in childhood-onset systemic lupus erythematosus.Non-alcoholic fatty liver disease: a diabetologist's perspective.Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.Tumour necrosis factor-α inhibition with lenalidomide alleviates tissue oxidative injury and apoptosis in ob/ob obese mice.Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.Physiological Effects Associated with Quinoa Consumption and Implications for Research Involving Humans: a Review.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.Body Mass Index as a Measure of Obesity: Racial Differences in Predictive Value for Health Parameters During Pregnancy.iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats.Pro-inflammatory cytokines mediate GPCR dysfunction.

P2860

Q24186092-50588AC2-8764-4345-927C-AB6B83126B8A Q24188095-B6D3363E-7DC0-4DF8-9CB8-87745E21D118 Q26749072-31104E70-9C84-44D3-9B0B-8A703E6DA819 Q26852584-EB4DA88C-7C0B-4292-8A42-26863FAE5925 Q33560216-A3F98D97-E6DF-40E2-BD21-C582D9F71EE2 Q33598219-7A7A5D1F-391C-41EB-A8E6-B819459E4613 Q33759547-AAC29176-3601-44AA-9D35-71970C7F444C Q33805550-350A9857-7DEE-4853-A87C-077AC31BB27A Q33825040-21ADBE77-0E43-4B0C-9A14-27A16B332732 Q33908808-ADD7FA79-20BD-404B-98A7-50A5F97D34B3 Q34006048-F2A80BF2-A1DF-4CA1-9307-AB52977F632B Q34027879-58B20D4C-E945-4611-9F0A-453F9D94C941 Q34038212-9E982E9D-0A99-43D2-980F-E2A2353669A1 Q34042152-262EE751-B106-48E5-B0DF-B2BC55B240F5 Q34072214-07508151-672C-4F1B-8EF4-E332158D9D2F Q34976833-49B72404-84BE-44EB-8E50-0938422F2D22 Q35176319-26D3062B-330F-48EB-BA60-BDAA21447B37 Q35242261-B9BA8C77-E300-4BA9-BD2B-E5592383AC8C Q35680361-C53FC6FE-5DC7-46A4-B7F3-F468D5F7EC9C Q35728214-45004C98-5F76-46E6-A8EA-5D124C3B1738 Q35743078-20A74F4A-D3DE-4882-868A-EFD42D19F760 Q36253207-C659C01F-7585-4641-B7D2-EB09692C14AF Q36289672-AABE521D-C619-4852-A827-E14BD512F772 Q36929032-B696D415-9043-4D04-BC78-215DF79C25E6 Q36929124-93CA5E1C-A7B7-4D8C-B7F1-34EE0ECCCF11 Q36984319-07747D78-7A96-452D-BBDC-E5BD48040FE7 Q37207028-E50F0AED-0BB1-4683-81EB-143F74EFAB71 Q37235370-9873886F-3FE3-4165-B51B-354B77954411 Q37549359-F873DF62-55FD-4981-B2FE-76B14AF79F49 Q37579475-51269A07-B86E-4E77-A9C0-32C17338A429 Q37704576-B296A916-B34B-46F7-9AE7-19DF00E5A89E Q38167264-A71903F0-06AA-4608-8D6A-76560B4E6133 Q38254986-2C008AAB-1F3E-4136-AFD1-AC82655282B6 Q38307733-FF0F1BCA-1211-4B21-A507-BB035432C0BE Q38380655-7E5B2FBA-995C-48B2-8CDD-F15B317C5402 Q38561953-608DE039-25E2-4779-8F10-2B5DEEE7863C Q38741861-CDFCF996-7059-4DC3-9838-717D97AB513B Q38917157-962F7F28-B306-48FC-91B8-BFA52A7DCA7E Q39038552-B7C636E0-FB36-41D5-9C7A-D164ECD5206F Q39070066-A3624E89-0BEE-46D4-9B5A-3FE9E26CD74D

P2860

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

http://www.wikidata.org/entity/Q36838201

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

@en

type

label

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

@en

prefLabel

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

@en

P1433

Q36838201-4CBCDF30-260F-4930-8F6D-C8CF74D7561B

P1476

Q36838201-AD423920-EC4B-4CF6-8ADF-CAD00FD13DE2

P2093

Q36838201-406A7141-FEF5-4F16-811B-E11D19EE4250

Q36838201-623D9865-2581-479D-B0E1-23056DE8AD37

Q36838201-9A2462B0-3E72-429D-B281-37F33893578D

Q36838201-C05BB15C-D5B8-4731-B7D4-EE61A61BB86A

P2860

Q36838201-014E818D-8B01-45AC-8886-16AF34537BF9

Q36838201-025B3390-A341-4332-8FFC-CD7DFB7A47E1

Q36838201-04FEE8B6-E31F-48F4-BB1A-1BC8821D71BF

Q36838201-05722456-5D1B-4377-AAB4-AB70025B5BA4

Q36838201-07DB2E9C-D354-438E-8212-007E10CBF01E

Q36838201-0B34E90A-1E36-4CCD-914C-5930EE6B70EA

Q36838201-0C8283E3-107D-483C-AE19-2AE6E9889D58

Q36838201-1041A343-6164-4896-A9A1-8290C1043B5D

Q36838201-11152112-9174-4D09-82A1-B42C0CEFA253

Q36838201-12044095-1129-4C3A-8978-7E5585516AC8

P304

Q36838201-5A28F8E5-44AD-4B9A-9DFA-BA70DCDCE9DE

P31

Q36838201-082AD0F6-A992-46E3-A963-29256632E24A

P356

Q36838201-C0644E97-6C8E-436A-8BDB-5805E1A8AD7C

P478

Q36838201-3AFDEB7B-8BB8-4A8A-8614-CC85668D84A6

P577

Q36838201-C05D1BAB-7E63-4C12-8A1F-17C374CF315E

P5875

Q36838201-78D48950-F57C-482E-A7DE-1CE2E82541E5

P698

Q36838201-E91B2227-7F25-4570-BBBE-1E2A473F0E10

P921

Q36838201-CFCCE293-8943-45C9-940F-038396877CA1

P932

Q36838201-AD13F356-294B-48AB-9E99-9D6D02C3A7E0

P356

P1433

International journal of endocrinology

P1476

Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

@en

P2093

Gabriela Rodríguez-Ramírez

http://www.w3.org/2001/XMLSchema#string

Heriberto Rodríguez-Hernández

http://www.w3.org/2001/XMLSchema#string

Luis E Simental-Mendía

http://www.w3.org/2001/XMLSchema#string

Miguel A Reyes-Romero

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Inflammation, stress, and diabetes

Mechanism of free fatty acid-induced insulin resistance in humans

The inflammasome: in memory of Dr. Jurg Tschopp

C-reactive protein: a critical update

Dietary patterns, inflammation and the metabolic syndrome

Inflammation and metabolic disorders

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

C-reactive protein, antiinflammatory drugs, and quality of life in diabetes

P304

678159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/678159

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236924961

http://www.w3.org/2001/XMLSchema#string

P698

23690772

http://www.w3.org/2001/XMLSchema#string

P921

P932

3652163

http://www.w3.org/2001/XMLSchema#string